- Home
- VKTX vs JHG Comparison
VKTX vs JHG Comparison
Compare VKTX & JHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- JHG
- Stock Information
- Founded
- VKTX 2012
- JHG 1934
- Country
- VKTX United States
- JHG United Kingdom
- Employees
- VKTX N/A
- JHG N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- JHG Investment Managers
- Sector
- VKTX Health Care
- JHG Finance
- Exchange
- VKTX Nasdaq
- JHG Nasdaq
- Market Cap
- VKTX 4.7B
- JHG 6.9B
- IPO Year
- VKTX 2015
- JHG N/A
- Fundamental
- Price
- VKTX $41.49
- JHG $42.71
- Analyst Decision
- VKTX Strong Buy
- JHG Hold
- Analyst Count
- VKTX 12
- JHG 11
- Target Price
- VKTX $106.75
- JHG $41.00
- AVG Volume (30 Days)
- VKTX 3.6M
- JHG 1.0M
- Earning Date
- VKTX 02-05-2025
- JHG 01-30-2025
- Dividend Yield
- VKTX N/A
- JHG 3.67%
- EPS Growth
- VKTX N/A
- JHG 24.92
- EPS
- VKTX N/A
- JHG 2.53
- Revenue
- VKTX N/A
- JHG $2,333,400,000.00
- Revenue This Year
- VKTX N/A
- JHG $18.99
- Revenue Next Year
- VKTX N/A
- JHG $8.68
- P/E Ratio
- VKTX N/A
- JHG $16.79
- Revenue Growth
- VKTX N/A
- JHG 13.91
- 52 Week Low
- VKTX $17.23
- JHG $28.19
- 52 Week High
- VKTX $99.41
- JHG $45.74
- Technical
- Relative Strength Index (RSI)
- VKTX 35.23
- JHG 46.44
- Support Level
- VKTX $39.09
- JHG $41.37
- Resistance Level
- VKTX $43.48
- JHG $43.75
- Average True Range (ATR)
- VKTX 2.15
- JHG 0.86
- MACD
- VKTX 0.10
- JHG -0.11
- Stochastic Oscillator
- VKTX 28.04
- JHG 47.21
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About JHG Janus Henderson Group plc
Janus Henderson Group provides investment management services to retail intermediary (56% of managed assets), self-directed (23%) and institutional (21%) clients. At the end of September 2024, active equities (63%), fixed-income (21%), multi-asset (14%) and alternative (2%) investment platforms constituted the company's $382.3 billion in assets under management. Janus Henderson sources most of its managed assets from clients in North America (61%), with customers from Europe, the Middle East, Africa, and Latin America (29%) and the Asia-Pacific region (10%) accounting for the remainder.